Tiziana Announces Last Patient Completes Last Visit In Phase 2A Inform-MS Trial Of Intranasal Foralumab
TLSA•Phase 2A Inform-MS trial update
- Tiziana Announces Last Patient Completes Last Visit In Phase 2A Inform-MS Trial Of Intranasal Foralumab
Sept. 21 (Reuters) - Tiziana Life Sciences Ltd TLSA.O:
- Tiziana announces last patient completes last visit in Phase 2A Inform-MS trial of intranasal foralumab
